Biotech / Medtech Archives | citybizSciencenews

Vor Bio Announces $75 Million Private Placement with TCGX

Friday, March 27, 2026William HarrisView original

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered... Read More

The post Vor Bio Announces $75 Million Private Placement with TCGX appeared first on citybiz.